Understanding Atrial Fibrillation: A Growing Global Health Concern

Heart rhythm disorders, particularly atrial fibrillation (AFib), are often silent threats, frequently going unnoticed despite their potential to trigger serious complications like stroke and heart failure. Cardiovascular disease remains the leading cause of death globally, accounting for an estimated 19.8 million deaths in 2022 [1]. Atrial fibrillation, the most common type of heart arrhythmia, demands increased awareness and proactive management.

The Rising Prevalence of AFib

Globally, an estimated 59–60 million people were living with atrial fibrillation in 2019 and this number continues to rise [3]. A significant challenge is that many individuals with AFib are asymptomatic, meaning they experience no noticeable symptoms. This often leads to delayed diagnosis and treatment, increasing the risk of adverse outcomes.

AFib and its Connection to Stroke

Arrhythmias are a significant health concern due to their link to heart disease and stroke [2]. Approximately one-third of individuals with atrial fibrillation exhibit no symptoms, and cases are often discovered only after complications, such as stroke, occur. Untreated AFib substantially elevates stroke risk, highlighting the critical importance of screening and early detection.

Data from Siloam Hospitals TB Simatupang reveals a strong correlation between arrhythmia and stroke. Between 2024 and 2025, around 33% of stroke patients examined with an ambulatory or Holter monitor were found to have an underlying arrhythmia [2]. 37% of stroke patients treated at the hospital were of productive age.

Challenges in AFib Management

Despite the increasing number of AFib patients, healthcare systems face several challenges. These include limited infrastructure and an uneven distribution of specialized arrhythmia personnel. Addressing these issues requires strengthening early detection efforts, expanding access to care, and developing a national, data-driven arrhythmia registry system.

Advancements in Detection and Treatment

Recent advancements offer hope for improved AFib management. Effective therapeutic approaches, such as catheter ablation, aim to restore a normal heart rhythm. Catheter ablation can not only improve a patient’s quality of life but also reduce stroke risk and potentially increase life expectancy [2].

Siloam International Hospitals has been strengthening integrated heart services across its network, supported by over 250 heart specialists and subspecialists. The hospital network performs over 2,100 heart operations and approximately 15,800 procedures in cardiac catheterization laboratories annually.

Raising Awareness: The “Let’s Check The Beat” Campaign

To increase public awareness of heart rhythm disorders, initiatives like Siloam Hospitals TB Simatupang’s “Let’s Check The Beat” educational campaign are crucial. This campaign encourages early detection through electrocardiogram (EKG) examinations and provides education on risk factors, prevention, and the latest treatment technologies.

Understanding Atrial Fibrillation: Key Takeaways

• Atrial fibrillation is the most common type of treated heart arrhythmia.
• Many individuals with AFib are unaware they have the condition due to a lack of symptoms.
• Untreated AFib significantly increases the risk of stroke.
• Early detection and treatment, including procedures like catheter ablation, are vital for improving outcomes.
• Increased awareness and access to care are essential for addressing the growing global burden of AFib.